The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

The recommendations were approved on May 13, 2025, and are now the official recommendations of the CDC. The final recommendations ... Valneva make vaccines for chikungunya.

Mosquitoes can tranmist dengue virus, which has already caused local cases in Florida in 2025... | Clinical And Molecular Dx ...

The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...

The CDC’s restricted communication under HHS oversight has hindered public awareness amid rising global disease outbreaks ...

Longer, hotter summers and shifting weather patterns — fueled by a warming planet — are bringing about more than just sunshine and higher temperatures. Mosquitoes are thriving earlier and later and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

While the ACIP made six recommendations in April, Kennedy has only endorsed three so far; they outline who can use newly licensed chikungunya vaccines. Three others, related to a new meningococcal ...